See more : New Zealand Oil & Gas Limited (NZO.NZ) Income Statement Analysis – Financial Results
Complete financial analysis of PAO Group, Inc. (PAOG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PAO Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Dongfeng Motor Group Company Limited (DNFGF) Income Statement Analysis – Financial Results
- Jindal Steel & Power Limited (JINDALSTEL.NS) Income Statement Analysis – Financial Results
- Innovative Food Holdings, Inc. (IVFH) Income Statement Analysis – Financial Results
- SIGMAXYZ Holdings Inc. (6088.T) Income Statement Analysis – Financial Results
- AMPACS Corporation (6743.TW) Income Statement Analysis – Financial Results
PAO Group, Inc. (PAOG)
About PAO Group, Inc.
PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 287.82K |
| Cost of Revenue | 0.00 | 2.74K | 1.80K | 0.00 | 0.00 | 250.12K |
| Gross Profit | 0.00 | -2.74K | -1.80K | 0.00 | 0.00 | 37.70K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 13.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 45.42K | 185.81K | 340.32K | 14.31K | 72.86K | 244.43K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -4.13K | 0.00 |
| Operating Expenses | 45.42K | 185.81K | 340.32K | 14.31K | 76.99K | 244.43K |
| Cost & Expenses | 45.42K | 188.55K | 342.12K | 14.31K | 76.98K | 494.55K |
| Interest Income | 0.00 | 0.00 | 97.53K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 57.46K | 62.61K | 55.72K | 35.89K | 58.53K | 103.76K |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K |
| EBITDA | 292.96K | -188.55K | -244.59K | -14.31K | 1.20M | -206.73K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -71.83% |
| Operating Income | -45.42K | -188.55K | -342.12K | -14.31K | -76.99K | -206.73K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -71.83% |
| Total Other Income/Expenses | 280.93K | -62.61K | 41.81K | -37.24K | 1.22M | -103.76K |
| Income Before Tax | 235.51K | -251.16K | -300.30K | -51.55K | 1.14M | -310.49K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -107.88% |
| Income Tax Expense | -167.90K | -228.49K | -236.56K | -206.30K | -171.86K | -161.14K |
| Net Income | 235.51K | -251.16K | -300.30K | -51.55K | 1.14M | -310.49K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -107.88% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 1.91B | 1.91B | 1.91B | 1.40B | 914.18M | 815.18M |
| Weighted Avg Shares Out (Dil) | 1.91B | 1.91B | 1.91B | 1.40B | 914.18M | 815.18M |
PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals
Sandusky, Ohio--(Newsfile Corp. - February 18, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the...
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
Sandusky, Ohio--(Newsfile Corp. - February 16, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today published an online, multimedia presentation detailing the Company's CBD nutraceutical development expansion plans. The CBD nutraceutical development expansion plans are anticipated to generate revenue beginning...
PAOG Targets $18 Billion Anxiety And Depression Treatment Market
Sandusky, OH, February 11, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced the company's recently announced CBD nutraceutical development expansion will target the anxiety and depression treatment market anticipated to reach a value of...
PAOG Targets $18 Billion Anxiety And Depression Treatment Market
Sandusky, Ohio--(Newsfile Corp. - February 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company's recently announced CBD nutraceutical development expansion will target the anxiety and depression treatment market anticipated to reach a value of $18 billion...
PAOG Plans To Add CBD Nutraceutical Revenue In 2021 To Cannabis Cultivation Revenue
Sandusky, OH, February 10, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced the company plans to add revenue this year in 2021 from its developing CBD nutraceutical business to currently anticipated revenue from its...
PAOG Plans To Add CBD Nutraceutical Revenue In 2021 To Cannabis Cultivation Revenue
Sandusky, Ohio--(Newsfile Corp. - February 10, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company plans to add revenue this year in 2021 from its developing CBD nutraceutical business to currently anticipated revenue from its cannabis cultivation...
PAOG Announces CBD Nutraceuticals Expansion Plan For $3.8 Billion Market Presentation Scheduled Next Week
Sandusky, OH, February 8, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced plans to publish a multimedia presentation next week on the company's strategy to expand its nutraceutical product reach. The company plans to...
PAOG Announces CBD Nutraceuticals Expansion Plan for $3.8 Billion Market Presentation Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - February 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to publish a multimedia presentation next week on the company's strategy to expand its nutraceutical product reach. The company plans to produce nutraceuticals...
PAOG To Expand Revenue Base Introducing New CBD Nutraceuticals Targeting $3.8 Billion Market
Sandusky, Ohio, February 4, 2021 – OTC PR WIRE – PAO Group, Inc. (OTC Pink: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care...
PAOG Confirms $300,000 Sales Agreement With Cannabis Cultivation Subsidiary
Sandusky, OH, February 3, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed a $300,000 sales agreement executed by the company's cannabis cultivation subsidiary. PAOG anticipates approximately $50,000 in revenue per quarter for six quarters...
Source: https://incomestatements.info
Category: Stock Reports